UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004482
Receipt No. R000005362
Scientific Title Phase II Study of Adoptive Immunotherapy Comprising 2-Methyl-3-Butenyl-1-Pyrophosphate-Stimulated Gamma Delta T Cells, Teceleukin, and Zoledronic acid in Patients With Stage IV Renal Cell Carcinoma
Date of disclosure of the study information 2011/01/15
Last modified on 2014/06/23 10:32:49

No. Disposal Last modified on Item of update
1 Insert 2010/10/30 13:38:56
2 Update 2010/11/26 20:42:49 Date of disclosure of the study information
3 Update 2011/01/17 17:49:14 Recruitment status
4 Update 2014/06/23 10:28:01 TEL
Email
Last name of contact person
Last name of contact person
Address
Address
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
5 Update 2014/06/23 10:32:49 Recruitment status


Contact us.